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[571 ABSTRACT 
Normal mammalian tissue and the culturing process has 
been developed for the three groups of organ, structural and 
blood tissue. The cells are grown in vitro under microgravity 
culture conditions and form three dimensional cells aggre- 
gates with normal cell function. The microgravity culture 
conditions may be microgravity or simulated microgravity 
created in a horizontal rotating wall culture vessel. 
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MEDIA COMPOSITIONS FOR THREE- 
DIMENSIONAL MAMMALIAN TISSUE 
GROWTH UNDER MICROGRAVITY 
CULTURE CONDITIONS 
A variety of different cells and tissues, such as bone 
marrow, skin, liver, pancreas, mucosal epithelium, adeno- 
carcinoma and melanoma, have been grown in culture 
systems to provide three dimensional growth in the presence 
5 of a preestablished stromal support matrix. U.S. Pat. No. 
4,963,489, Three-Dimensional Cell and Tissue Culture This is a divisional of application Ser, No, 081066,292 
filed May 25, 1993, now U,S, Pat, No, 5,496,722, which is 
a continuation-in-part of application Ser, No, 07,/939,791, 
filed Sep, 3, 1992, now U,S, Pat, No, 5,308,764, which is a 
System, Naughton, et al., Oct. 16, 1990; u.s. Pat. No. 
5,032,508, Three-Dimensiona1 
System, 
and Tissue 
et Jul. 16, 1991. A biocompatible, 
continuation of application Ser, No, 071317,391, filed Mar, non-living material formed into a three dimensional struc- 
2, 1989, now u,s, Pat, No, 5,153,132, which is a ture is inoculated with stromal cells. In some cases, the three 
continuation-in-part of application Ser, No, 071317,776, dimensional structure is a mesh pre-coated with collagen. 
filed Mar, 2, 1989, now u,s, Pat, No, 5,155,034, which is a Stromal cells and the associated connective tissue proteins 
filed Juri, 30, 1988, now u,s, Pat, No, 5,235 161; and this is 1s the three dimensional structure. The interstitial spaces of the 
559, filed Juri, 30, 1988, now u,s, Pat, No, 4,988,623, and grown to at least subconfluence prior to inoculating the three 
a continuation-in-part of application Ser, No, 07625,345, dimensional stromal matrix with tissue-specific cells. 
filed Dec. 11, 1990, now U.S. Pat. No. 5,153,131, Normal mammalian tissue has been grown for limited 
2o periods of time as two-dimensional monolayers on gelled 
substrate or other surface for anchoring the cells. Adult 
colonic epithelial cells have been found to be more difficult 
The invention described herein was made in the Perfor- to culture than fetal colonic epithelial cells. Buset et al. 
mance of work under a NASA contract and is subject to the “ ~ ~ f i ~ i ~ ~  Conditions to promote the Attachment of Adult 
provisions of Section 305 of the National Aeronautics and 2s H~~~~ colonic Epithelial cells”, zn Wtv0 cell, & D ~ ~ ,  ~ i ~ l , ,  
Space Act of 1958, h b l i c  Law 85-568 (72 Stat. 435; 42 Vol. 23. No. 6 pp. 403-412 (June 1987). To mimic a more 
U.S.C. 2457). normal environment using monolayer culture, cocultures 
were prepared using two cell types, often with a “feeder 
layer” of fibroblasts or other cells to supply the primary cells 
ne invention relates to production of functional three 30 with nutrients and other factors difficult to incorporate into 
a substrate and to provide the cellular interaction believed to 
be necessary for the production of differentiated tissue. Reid 
et al., “Culturing Hepatocytes and Other Differentiated 
Cells”, Hepatology, Vol. 4, No. 3, pp. 548-559 (1984); 
35 Haake et al. “Retention of Differentiated Characteristics in 
The culturing of mmmdian  cells Presents many Chd- Human Fetal Keratinocytes In Vitro”, Zn vltvo Cell. & Dev. 
lenges as compared to bacteria, yeast and molds. Bacterial- ~ i ~ l , ,  vel, 25 N ~ ,  25 pp, 592-600 (jUly 1989). dso, 
type cells have tougher outer cell walls and can be manipu- mono~ayers “conditionep with fibroblast cells have been 
lated without injuring the cells during culture, whereas used to impart into the substrate the soluble growth factors 
mammalian cells are delicate and cannot withstand stress. 4o for epithelial cells, Kabalin et “clonal Growth of H~~~~ 
Bacterial-type cells are not organized into functional tissue prostatic Epithelial cells Stimulated by Fibroblasts”, ~h~ 
groups with cell differentiation or organization as seen in prostate, vel, 14, pp, 251-263 (1989). ~~~~l~~~~~ do not 
higher life forms such as mammals. produce a three dimensional tissue, but rather a two- 
Mammalian tissue can be grouped into three general dimensional spread of cells. Often the cells developed by 
categories of (1) organ tissue (2) structural tissue and (3) 45 monolayer culture and coculture become undifferentiated 
blood producing tissue. Mammalian tissue is composed of and lack normal function. 
aggregates of cells that share a functional interrelationship in Three dimensional in vitro models of differentiated tissue 
order to have tissue growth. Mammalian tissue is composed have been produced, however, the cells often do not dem- 
of different types of cells characterized by different mor- onstrate normal cellular activity. Embryonic avian skeletal 
phology and immunochemical properties. Cellular differen- 50 muscle cells have been grown in vitro on expandable 
tiation in mammals involves complex interactions in which membranes which are gradually and substantially, continu- 
cell membrane junctions, extracellular matrices such as ously stretched to simulate the mechanical stimulation of 
continuation-in-part of application Ser, No, 071213,588, secreted by the attach to and 
also a continuation-in-part of application Ser, No, 071213, structure become bridged by the which are 
ORIGIN OF THE INVENTION 
FIELD OF THE INVENTION 
dimensional mammalian tissue from a culture of normal 
cells in fluid media. 
BACKGROUND OF THE INVENTION 
basement membrane and ground substances. Soluble signals 
produced and shared among the cells play an important role. 
cells experienced in vivo. U.S. Pat. No. 4,940,853, Method 
for Growing Tissue Specimens in Vitro, Vadenburgh, Jul. 10, 
Study of normal mammalian tissue, however, has been ss 1990. The expandable support membrane supports develop- 
ment of three dimensional structures which more closely 
that product tissue of sufficient size and functionality. In resemble tissue grown in vivo, however, normal indepen- 
dent cellular activity was not identified. Additionally, three 
vitro, possess abnormal growth characteristics and do not dimensional human mammary epithelial cells have been 
behave like normal cells in their interaction with neighbor- 60 grown in collagen. U.S. Pat. No. 5,026,637, Soule, et al., 
ing cells. Sutherland, “Cell and Environment Interactions in Jun. 25, 1991. However, the cells, under the culture 
Tumor Microregions: The Multicell Spheroid Model’’, conditions, did not undergo terminal differentiation and cell 
Science, vel. 240, pp. 177-240, 8 Apr. 1988. Different senescence, but rather were “immortal” in that they retained 
culture methods for normal and abnormal mammalian cells the capacity to divide forever. Thus, normal cellular activity 
have been used. Elaborate culture systems for normal mam- 6s and naturalization was not observed. 
malian cells have been developed in an attempt to grow The study of the organ systems exemplifies the complex 
normal tissue. interrelationship of neighboring cells in mammalian tissue 
limited because of lack of adequate in vitro culture systems 
contrast, tumor cells are by their nature easier to grow in 
5,846,807 
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necessary for normal three dimensional tissue growth. Mam- into the interstitial matrices. These maneuvers include vari- 
malian organ systems have been studied to determine the ous growth factor augmentations, an effort to emulate in situ 
relationship of the cell types that make up the organ as well conditions. The extent to which the cells can be maintained 
as their effects on each other. Studies on normal tissue in situ is on the order of tens of years as Seen in the normal 
differentiation have indicated an important interaction 5 adult, conversely, in standard cell culture the extent which 
between ePlthella1 cells and mesenchymal cells and the cells can be maintained in a growth phase or a normal static 
production and differentiation of the cells from fibroblasts. maintenance phase is on the order of 22 days, has been 
Kaye et al., “The Pericryptal Sheath: demonstrated that multiple cell-surface receptors exist that 
Replication, Migration, and Cytodifferentiation of a Mesen- are important in cellular growth and differentiation, and 
c h ~ m a l  Cell System in Adult Tissue” Gastroenterology, Val. 10 extracellular matrix formation. Cell surface receptors are 
60. No. 4, pp. 515-536 (1971). Furthermore, small intestine labile to destructive cell surface sheer, 
tissue is exemplary of organ tissue types with epithelial cells Cartilage cells were reportedly cultured for 13 months with functional brush borders and organized columnar cells using a solid substrate in conventional culture vessels. U.S. 
Pat. No. 4,757,017 Cheung et al., Jul. 12, 1988. The solid associated with mesenchymal cells. Other organs have simi- lar organization. Small intestine tissue has physical support 
15 substrate was a porous calcium compound. Multilayer cell in vivo so that the tissue forms crypts which increase the growth was observed and the cells maintained their pheno- surface area of the organ. In addition to the crypt formation 
in vivo, there are also immunocytochemical markers for type’ 
particular cell types with normal functionality as well as cell mono- 
types that are in developmental phases to produce functional layer culture technique. Human bone marrow 
organ tissue. 2o ture technique. Human bone marrow cell production 
Immunochemical properties further characterize normal declines over time in monolayer culture. Naughton et. al. 
cells types and tissue, Keratin, vimentin and Factor vIII disclosed a bone marrow culture system in co-culture with 
antibodies detect epithelial, fibroblastic and endothelial cells 
respectively, Villin is a cytoskeletal protein only found in 25 support. u.s. Pat. No. 4,963,489. The three 
angioblast marker is present in certain precursor endothelial ‘‘‘lagen layer On a mesh support. 
cells, particularly dividing cells. Sucrase is an enzyme found h b m d i a n  tissue has been grown in bioreactors Provid- 
in the epithelial cell brush border of the small intestine. ing low shear from abnormal cell types such as t m ~ o r  cells 
Basement membrane and extracellular matrix components 3o Or cocultures with  mal and tumor cells. Goodwin et al., 
such as laminin, fibronectin, Collagen IV, and proteoglycan “MoThological Differentiation of Ckhn C a r c i m ~ ~ ~  Cell 
are associated with ordering of tissue and cellular polarity, Lines HT-29 and HT-29K in Rotating-Wall Vessels,” In Vitro 
Basement membrane and extracellular matrix development Cell. Dev B i d .  VOl. 28A, PP. 47-60? January 1992. The 
has been related to epithe~ia~-mesenchyma~ development bioreactor designs are disclosed in U.S. Pat. Nos. 4,988,623; 
and differentiation. All these components are necessary for 35 5,026650 and 521533131. ~o-culture of twmr and normal 
normal tissue growth. cells in solid-state culture has been reported as shown in 
Culture of normal or neoplastic small intestine epithelium U S .  Pat. No. 4,352,887 to Reid et al. issued Oct. 5, 1982. 
shown with routinely used in vitro culture technology, tions that normal cells cannot tolerate, the growth of non- 
Chantret et “ ~ ~ i ~ h ~ l i ~ l  polarity, villin ~~~~~~~i~~ and 4o normal cells does not predict success for normal mammalian 
~~~~~~~~i~ i f f ~ ~ ~ ~ ~ i ~ ~ i ~ ~  of cultured H~~ ~ colon carci- culture under the same or similar culture conditions. 
noma Cells: A survey of Twenty Cell Lines” Cancer Res., There are many potential uses of artificially produced 
Vol. 48, pp. 1936-1942 (Apr. 1, 1988). Factors that control tissue for different mammalian systems. For example, small 
proliferation and differentiation in the gastrointestinal tract intestine tissue can be used as a model for the molecular and 
remain largely unknown. corps et al., ‘‘Stimulation of Intes- 45 clinical treatment of diseases such as inflammatory bowel 
tinal Epithelial Cell Proliferation in Culture by Growth disease (Crohn’s, ulcerative colitus), malabsorptive syn- 
Factors in Human and Ruminant Mammary Secretions” J .  dromes (short-gut syndrome), numerous infectious diseases 
Endocr., vel. 113, pp. 285-290 (3 Nov. 1986); O’Loughlin and tumors of the small bowel. The tissue can be a model for 
et al., ‘‘Effect of Epidermal Growth Factor on Ontogeny of the therapeutic trials prior to in vivo experimentation. How- 
the Gastrointestinal Tract” Am. J .  Physiol., Vol. 249, pp. 50 ever cultures longer than 7 weeks have been difficult to 
G674-G678 (8 Jul. 1985); Blay et al., ‘‘Contradistinctive achieve, since crypt cells are unable to survive standard 
Growth Responses of Cultured Rat Intestinal Epithelial culture regimens, and two-dimensional organ cultures do not 
Cells to Epidermal Growth Factor Depending on Cell Popu- support the de novo assembly of stroma and its contribution 
lation Density” J.  of Cell. Physiol., vel. 129, pp.343-346 (15 to epithelial cell growth. Shamsuddin, “Colon Organ Culture 
Jul. 1986). 55 as a Model for Carcinogenesis”, Colon Cancer Cells, Moyer 
Cartilage tissue is exemplary of normals structural tissue. and Paste, Eds. Academic Press, Inc. 1990. 
Attempts have been made to encourage cartilage formation Also, a mammalian structural tissue such as a cartilage 
in vitro by culturing chondrocytes. Typical culture durations model of high fidelity is important in clinical studies. There 
achieved in the more successful instances range from 10 are numerous maladies associated with cartilage, including 
days to 30 days, the 30-day point being a transition towards 60 but not limited to knee-joint injuries, back injuries, articular- 
static culture or cellular degeneration and death. The success surface injuries, inflammatory diseases such as arthritis and 
achieved to date has had limited 3-dimensionality. Typical temporal-mandibular joint disease. Beyond the diseases are 
cell culture methodologies include isolating chondrocytes the natural processes of maturation through puberty and the 
from various articular surfaces and plating the isolated geriatric inability to repair and maintain articular surfaces. A 
chondrocytes as a monolayer in a T-flask. Various manipu- 65 tissue model would be beneficial for the analyses and 
lations were then utilized to encourage chondrocyte expan- development of therapeutic protocols. Moreover, these mod- 
sion and differentiation, and the deposition of proteoglycan els become essential in tailoring pharmaceuticals, i.e.; non- 
Bone marrow has been grown 
Or mixtures Of types On a three 
epithelial cells from the small intestine and colon, The was coated by as Over a 
as large-scale three dimensional configurations has not been However, since tumor or abnormal cells grow under condi- 
5,846,807 
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steroidal anti-inflammatories where the pharmaceutical may 
actually become detrimental to the chondrocyte by way of 
degradation into secondary metabolites. 
The artificial production of functional blood tissue such as 
normal bone marrow could be used in patients in need of 
bone marrow replacement which have lost the ability to 
produce the tissue. The tissue could be grown from a sample 
and transplanted back to the patient. Also, bone marrow 
material can be transplanted into a non-autologous recipient. 
SUMMARY OF THE INVENTION 
Aggregates of normal mammalian cells have been pro- 
duced in vitro for each of the three major tissue groups. The 
cell aggregates exhibited three dimensional tissue growth 
and functional interrelationship by cell to cell contact. 
Functional cells with normal morphology have been pro- 
duced for organ, structural and blood producing tissues. Cell 
function was in some cases confirmed immunohistochemi- 
cally by antibodies specific to particular cellular components 
characterizing cell types. 
The aggregates were produced under “microgravity cul- 
ture conditions” which can be microgravity or simulated 
microgravity. Simulated microgravity was created in unit 
gravity by controlling the horizontal rotation of a culture 
vessel containing normal mammalian cells, culture matrix 
and completely filled with culture media. In the preferred 
process a horizontally rotating wall culture vessel produced 
the simultaneous conditions of (1) collocation of cells and 
culture matrix with similar or differing sedimentation prop- 
erties in a similar spatial region, (2) freedom for three 
dimensional spatial orientation of tissues formed by the 
culturing of the cells and (3) low shear and essentially no 
relative motion of the culture environment with respect to 
the walls of the culture vessel. The culture conditions 
included mass transfer under microgravity conditions with 
exchange of nutrients for metabolic waste and appropriate 
gas exchange in the culture system. 
The process for producing the normal mammalian tissue 
is particularly unique in that the resultant product is normal 
tissue of a size of 2 millimeters and larger. The size of the 
tissue cultured is significant because assembly of three 
dimensional masses of this size is not possible without the 
complex functional interrelationship of the normal mamma- 
lian cells. 
Functional three dimensional organ tissue masses have 
been produced artificially from an inoculum of predomi- 
nantly normal differentiated epithelial cells and predomi- 
nantly normal differentiated mesenchymal cells. The epithe- 
lial and mesenchymal cells were preferably disassociated 
prior to introduction into the culture vessel. The epithelial 
and mesenchymal cells were introduced in a vessel with a 
culture matrix preferably of generally spherical microcarri- 
ers. Tissue engineering was achieved by selected introduc- 
tion of the mesenchymal cells and culture matrix for a 
preselected culture period prior to transfer of epithelial cells 
to the culture vessel. 
A three dimensional normal organ tissue mass grew in 
association with the culture matrix having functional epi- 
thelial cells and functional mesenchymal cells. Also, the 
tissue developed cells immunochemically characterized as 
functional endothelial precursor cells in significantly greater 
numbers than were present in the initial inoculum. The organ 
tissue mass also developed cells immunochemically char- 
acterized as functional angioblasts and cells that were immu- 
nochemically characterized as functional epithelial cell 
brush borders. Organized columnar cells were clearly vis- 
6 
ible. The developing organ tissue included cells immu- 
nochemically characterized as basement membrane compo- 
nents. As the tissue masses grew anchored to microcarriers 
they were joined with cord-like structures of fibroblasts 
A preferred fluid media for mammalian organ tissue 
culture is a MEM (minimum essential medium) base with a 
tri-sugar supplement and fetal bovine serum. The preferred 
tri-sugar supplement is selected from mixtures of fructose, 
The organ tissue can be initiated by various normal 
mammalian organ cells including skin, small intestine, 
pancreas, liver, colon, and endocrine gland. Predominantly 
normal terminally differentiated cells were able to revert to 
a state that allowed interaction of a growing cellular mass 
capable of normal organ tissue evolution without using 
non-differentiated cells and without using cell types such as 
tumor cells that have abnormal cell growth characteristics. 
Artificially produced structural tissue has been produced 
in microgravity culture conditions from normal structural 
tissue. The three dimensional structural tissue mass devel- 
oped with functional chondrocytes and stromal cells with 
tissue calcification. The tissue exhibited matrix deposition 
including cells immunochemically characterized as produc- 
ing Type IV, Type IX and Type X collagen. The structural 
tissue is cultured in a vessel at microgravity conditions as 
described herein with a culture matrix. A preferred culture 
matrix was generally spherical microcarriers. An initial 
3o inoculum used in the process to produce the structural tissue 
mass was nonhuman embryonic cartilage cells disassociated 
prior to transfer to the culture vessel. 
Three dimensional mammalian blood tissue of normal 
origin has been produced artificially. The bone marrow 
35 tissue was prepared from normal bone marrow cells. The 
inoculum from the bone marrow include pleuripotential 
stem cells, fully matured white blood cells and red blood 
cells. The bone marrow cells were transferred into a culture 
vessel with fluid culture media and culture matrix. Micro- 
40 gravity culture conditions as described herein were main- 
tained while three dimensional tissue growth was achieved. 
The culture matrix can be disc-shaped. The bone marrow 
can be encased in stromal-like matrices and introduced into 
the vessel. Also, culture matrix of Type I rat tail collagen and 
Relatively large normal mammalian three dimensional 
tissue masses were cultured using microgravity culture 
conditions. The ability of the cells to grow into large 
aggregates supports the functional relationship achieved by 
SO cell to cell contact of normal cells. The process and normal 
tissue of this invention can be used advantageously as an in 
vitro produced mammalian product. 
s covered by epithelial cells. 
10 galactose and glucose. 
20 . 
25 . 
45 biopolymers can be used. 
BRIEF DESCRIPTION OF THE DRAWINGS 
55 FIG. 1 is a view at 200x magnification of a three dimen- 
FIG. 2 is a photograph of artificial normal organ tissue at 
FIG. 3 is a photograph of artificial normal organ tissue at 
FIG. 4 is a photograph of artificial normal organ tissue at 
FIG. 5 is a photograph of artificial normal organ tissue at 
FIG. 6 is a photograph of artificial normal structured 
sional artificial normal organ tissue mass. 
200x magnification. 
500x magnification. 
1500x magnification. 
60 
65 50x magnification. 
tissue at 500x magnification. 
5,846,807 
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FIG. 7 is a photograph of artificial normal structural tissue 
FIG. 8 is a photograph of artificial normal structural tissue 
FIG. 9 is a photograph of artificial normal structural tissue 
FIG. 10 is a schematic drawing of the blood producing 
at 1500x magnification. 
at 200x magnification. 
at 1500x magnification. 
tissue cells and microcarriers. 
DETAILED DESCRIPTION OF THE 
INVENTION 
Aggregates of cells from the three major tissue groups 
were cultured in vitro. The artificially produced tissue 
masses exhibited normal morphology and cell function. 
Examples of organ tissue, structural tissue and blood tissue 
are described below. 
The artificially produced mammalian organ tissue was 
generated from normal small intestine epithelial and mes- 
enchymal cells. Human small intestine epithelial and mes- 
enchymal cells were obtained from normal organs of 
patients, predominantly organ transplant donors, with no 
evidence of disease. The cells were then propagated in 
culture. The cells were initiated and propagated in M3 media 
supplemented with 2% fetal bovine serum (FBS), designated 
M3:2, for epithelial cells or with 10% FBS, designated 
M3:10, for mesenchymal cells. M3 medium is a complex 
base medium supplemented with many growth factors and 
nutrients including L-Broth (tryptone broth), bovine pitu- 
itary extract, hydrocortizone, essential and non-essential 
amino acids, pentagastrin, epidermal growth factor, 
transferrin, selenium, and insulin. Moyer, “Methods for 
Propagation and Characterization of Human GI and Other 
Cells for Study of HIV,” J .  Tiss. Cult. Meth., Vol. 13, pp. 
107-116 (1991). 
All cell cultures were grown in a Forma humidified CO, 
incubator with 95% air, 5% CO,, and constant atmosphere 
at a temperature of 37” C. Normal mesenchymal cells were 
passaged as required by enzymatic dissociation with a 
solution of 0.1% Trypsin, 0.1% EDTA, for 15 minutes at 37” 
C. After incubation with the appropriate enzymes, the cells 
were centrifuged at 800xG for 10 minutes in Corning 
conical 15-ml centrifuge tubes. The cells were then resus- 
pended in fresh medium and diluted into Corning T-flasks 
with 25 ml of fresh growth medium. Small intestine epithe- 
lial cells were passaged by dilution at a 1:2 ratio into fresh 
M3:2 medium in T-flasks. Cultures of epithelial cells were 
derived from the ileum and jejunum of three male donors 
(22-35 years of age). Mesenchymal cells were obtained 
from the submucosa of five donors (4 males, 17-27 years 
old, and a 2-month-old female). 
Normal mesenchymal cells were removed from T-75 
flasks by enzymatic digestion, washed once with calcium- 
and magnesium-free PBS (CMF-PBS), and assayed for 
viability by Trypan Blue dye exclusion (GIBCO). Cells were 
held on ice in fresh growth medium until inoculation. In the 
preferred process the primary inoculum introduced into the 
culture vessel was 2x10’ mesenchymal cellsiml in a 125-ml 
volume with 5 mgiml Cytodex-3 microcarrier beads 
(Pharmacia, Piscataway, N.J.). Cytodex-3 microcarriers 
were Type I, collage-coated dextran beads, 175 microns in 
diameter. After the primary inoculum was prepared for 
seeding, it was transferred to a culture vessel filled with 
culture media and cultured at microgravity conditions. 
In a preferred method the microgravity conditions were 
simulated in unit gravity by a horizontal rotating wall vessel 
(RWV). A preferred RWV bioreactor is described in U.S. 
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Pat. No. 5,026,650 to Schwarz et al. issued Jun. 25,1991 and 
is incorporated by reference herein. The rotation of the 
culture vessel (bioreactor) was controlled to produce the 
simultaneous conditions of (1) collocation of cells and 
culture matrix with similar or differing sedimentation prop- 
erties in a similar spatial region, (2) freedom for three 
dimensional spatial orientation of tissues formed by the 
culturing of the cells and (3) low shear and essentially no 
relative motion of the culture environment with respect to 
the walls of the culture vessel. The trajectory of the cell 
aggregates was determined. The speed of the rotation of the 
culture vessel was increased if the cell aggregates fell 
excessively inward and downward on the downward side of 
the rotational cycle and excessively outward and insuffi- 
ciently upward on the upgoing side of the rotational cycle to 
prevent wall impact. The rotation of the culture vessel was 
decreased in response to excessive accumulation of tissue 
aggregation near the outer wall of the culture vessel so as not 
to restrict three dimensional growth. As the tissue aggregates 
grow the rotation was adjusted to obtain minimal collision 
frequency and intensity. 
The culture media used in the RWV can be varied. A 1 : l  
mixture of M3:2 medium and standard minimal essential 
medium-alpha (MEM-alpha) .(GIBCO) supplemented with 
10% FBS was used. A preferred media designated GTSF-2 
was found to meet the growth requirements of the system 
without the need for unique growth factors and other com- 
plex components found in other media including M3:2. The 
GTSF-2 media is a trisugar-based medium with glucose, 
galactose and fructose supplemented with 6% FBS. A pre- 
ferred formulation for GTSF-2 media is listed in Table 1 
below. The pH was adjusted to 7.4 with 1N NaOH. 
TABLE 1 
Tri-Sugar Based Medium 
GTSF-2 
SourceiOrder 01 
Component Concentration Designation 
MEM-alpha supplemen- 
ted with 2.25 gmiL 
NaHCO, 
L-15 
NaHCO, 
HEPES 
Folic acid 
0.5% Nicotinic acid 
Bactopeptone 
I-inositol 
Fructose 
Galactose 
D-Glucose 
300mM L-Glutamine 
Gentamycin 
Fungizone 
Insulin-transferrin- 
sodium-solenite 
Fetal bovine serum 
400 ml (40%) 
600 ml (60%) 
1.35 gmiliter 
3.0 gmiliter 
6.667 ,@liter 
0.667 mliliter 
0.6 gmiliter 
0.024 gmiliter 
0.13 gmiliter 
0.25 gmiliter 
1.0 gmiliter 
10 mliliter 
1 mliliter 
2 mliliter 
5 mliliter 
60 ml (6%) 
GIBC01430-1900EB 
GIBC01430-1300EB 
Sigmais-5761 
Research Or- 
ganicsi6003H-2 
SigmaiF-8758 
SigmaiN-4126 
Difcoi0118-01 
SigmaiI-5125 
SigmaiF-3510 
SigmaiG-5388 
SigmaiG-5250 
SigmaiG-5763 
GIBC0/600-5750AD 
GIBC01600-5295AE 
SigmaiI-1884 
HycloneiA-1111-L 
The primary inoculum of mesenchymal cells was allowed 
to grow for a minimum of 2-3 days before the medium was 
changed. Then 2x10’ epithelial cellsiml were added pre- 
pared as described above for the mesenchymal cells. The 
organ tissue can be bioengineered to develop desired pat- 
terns of cell layering by preselecting the introduction of the 
epithelial cells into the culture vessel. Also, the cells can be 
introduced essentially simultaneously into the vessel to 
produce normal organ tissue. 
Culture conditions included mass transfer with exchange 
of nutrients for metabolic waste and appropriate gas 
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exchange in the culture system. Fresh medium was replen- Villin is a cytoskeletal protein only found in epithelial cells 
ished by 65% of the total vessel volume each 20 to 24 hours. from small intestine and colon. The angioblast marker is 
As metabolic requirements increased, fresh medium was present in subsets of precursor endothelial cells, particularly 
supplemented with an additional 100 mddl  of glucose. dividing cells. Sucrase is an enzyme found in the epithelial 
Viable cocultures grown in the RwvS were harvested Over s cell brush border of the small intestine. Basement membrane 
periods up to 45 days and prepared for various assays. and extracellular matrix components laminin, fibronectin, 
The artificial organ tissue mass was Produced in the R w v  Collagen IV, and proteoglycan were also assayed to deter- 
in both a 1:1 mixture of M3:2 and MEM alpha supplemented mine their expression in the artificially produced three 
with 10% fetal bovine serum (Hyclone Laboratories, Logan, dimensional tissues, 
Utah) and tri-sugar based media shown in Cultured organ tissue grown on Cytodex-3 microcarriers 
preferred culture matrix of 5 mdml  Cytodex-3 generally in the RWV were fixed in OmniFix, an alcohol-based 
spherical microcarriers (Pharmacia, LKB). The three dimen- fixative not containing aldehydes or mercury (Xenetics 
sional tissue cultures grown in the M3:2 and MEM media Biochemic, Tustin, calif,), At all times, extreme care was 
attained cell densities of 2.3-3.2~10’ cells/ml and although taken not to damage the delicate artificial tissue comprised 
potential for continued growth, the epithelial cell contingent dance of beads was present, the supernatant fluid was 
exhibited signs of considerable stress while the mesenchy- carefully decanted and a sample of beads was enclosed in a 
mal cells proliferated well. biopsy bag, then placed in a cassette to prepare a paraffin 
The Preferred tri-sugar based media was found to meet the block. When bead clusters were scarce, a Shandon Cytob- 
growth requirements without the need for multiple growth 20 lock Kit (Shandon Inc., Pittsburgh, Pa.) was used. Cassettes 
On a i o  
the cultures did not reach Plateau Phase, suggesting the 1s of cellular material and microcarrier beads. When an abun- 
factors and supplements. The cultures in the tri-sugar based 
media produced slightly higher average cell densities, 4.6 to 
which exhibited cell densities of 2 .5-3.2~10~ cells/ml. The 
were processed in a standard tissue processor, Five-micron 
sections were cut from the paraffin-embedded tissues, &par- 
with the test antibodies (Table 2) followed by use of the 
6.2X106 cellS/ml as compared to the M3:2 and MEM media affinized by standard procedures, then assayed by incubation 
three dimensional tissue mass grown in the tri-sugar based 2~ universal labeling streptavidin biotin (LSAB) kit (DMO 
media exhibited an epithelial cell component which Inc., Carpenteria, Calif., No. K680), which detects mouse 
appeared to Proliferate in a more m ~ m a l  and appropriate monoclonal and rabbit polyclonal antibodies. The immuno- 
fashion. The cultures were not grown to the Plateau Phase, cytophenotyping was confirmed by one positive and two 
indicating further capability for continued growth. The arti- negative controls, The positive control was normal tissue- 
ficial tissue did not reach maximum cell densities after 30 ,sections or normal cells positive for the primary antibody 
3845 days of culture. used. The negative controls were 1) PBS only, to test for 
The tissue masses grew to relatively large sizes as com- false binding by “link‘’ antibody and streptavidin, and 2) 
pared to other in vitro methods. After 300 hours of culture normal serum of the same species from which the primary 
the tissueimicrocarrier mass was about 0.2-0.3 cm in size antibody was prepared. 
with masses increasing to about 0.4-0.6 cm after approxi- 3 s  Analysis by immunocytochemistry was used to confirm 
mately 500 hours of culture and over 0.6 cm after 800 hours the ability of the seed cells to produce a three dimensional 
of culture. artificially produced tissue mass with functional epithelial 
The epithelial cells and mesenchymal cells used to seed cells and functional mesenchymal cells as well as functional 
the cultures were immunophenotyped and compared to the precursor endothelial cells that were not present in the seed 
three dimensional tissue cultured in the RWV. Samples were 40 culture. As the culture progressed and the tissue mass grew 
harvested at intervals during the culture process for immu- it included functional angioblasts. 
nocytochemical analysis. The antibodies used to immu- Immunophenotyping of the cell types used to seed the 
nochemically characterize the cell types are listed in Table coculture in the RWV confirmed the majority of epithelial 
2 below. and mesenchymal cells seeded were keratin and vimentin 
4s  positive, respectively. In addition, the epithelial cells were at 
various stages of differentiation. Only a small percentage 
( ~ 2 % )  of the cells was positive for Factor VIII, an endot- 
helial cell differentiation marker. Table 3 is a summary of the 
immunochemical staining reaction of the three dimensional 
Antibody Specificity Dilution Designation SO tissue of the present invention. The tissue was harvested at 
various intervals up to 41 days as noted in Table 3. 
An increased percentage >lo% of cells present in the 
Factor VI11 prediluted DAKO, Inc.IL1809 masses consisted of endothelial cells which were Factor VI11 
Villin 12.0 Chemicon, Temacria, positive as confirmed by immunochemistry and growing as 
ss patches on the beads. Furthermore, a small percentage, 
1-2% of cells, showed de novo expression of the HE3 
angioblast antigen which was not present in the seed cultures 
Laminin 12.0 ICN, Costa Mesa, CAl69- of mesenchymal cells confirming the presence of angioblasts 
in the tissue by immunochemistry. Functional cell brush 
60 borders were confirmed immunochemically by the presence 
FIG. 1 is a photograph of the small intestine artificially 
TABLE 2 
ANTIBoD1ES USED lMMUNoCYToCHEMICAL 
SourceiOrder No. or 
Pancytokeratin prediluted DAKO, Inc.lL1824 
Vimentin prediluted DAKO, Inc.IL1843 
CAIMAB 1671 
Sucrase 12.0 A. Elbein, UTHSCSAIYT 
Angioblasts 12.0 Accurate Chem, Westbu- 
ry CAlHE3-5/47 
630 
Fibronectin 12.0 US BIOCH, Cleveland, 
OH133752 
Proteoglycan 12.0 Biological Products for of sucrase. 
Science, Oxford, UWMCA 
326 produced organ tissue at 200x magnification showing the 
three dimensional cell aggregate generally indicated by the Collagen Type IV 1 2 0  DAKO, Inc.IM78S 
65 arrows. FIG. 2 is a photograph of the small intestine organ 
tissue. The triangular markers at 2 and 4 in the photograph 
are for reference on the microcarriers. A mass of epithelial 
The keratin, vimentin, and Factor VI11 antibodies detect 
epithelial, fibroblastic, and endothelial cells, respectively. 
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cells is shown at 6. Elongated mesenchymal cells are grow- 
ing on the microcarriers as shown at 8 and 10. FIG. 3 is a 
higher magnification (500x) of the epithelial mass shown at 
6 in FIG. 2. FIG. 4 shows the organized columnar epithelial 
cells of the small intestine organ tissue at arrows 12 and 14. 
FIG. 5 shows the three dimensional organ tissue masses 
joined by cord-like structures of fibroblasts (mesenchymal 
cells) covered by epithelial cells. 
TABLE 3 
SUMMARY OF IMMUNOCHEMICAL STAINING ON TISSUE 
GROWTH IN RWV* 
Specificity or Davs Grown in RWV 
Antibodies Cell Stained 13 23 25 37 41 
Keratin 
Vimentin 
Factor VI11 
Villin 
HE3 
Sucrase 
Laminin 
Fibronectin 
Proteoglycan 
C o 11 age n 
Type IV 
Epithelial, Cyto- 
skeletal 
Fibroblasts, some 
endothelial 
Endothelial 
Epithelial, small 
intestine 
Angioblasts 
Small intestine, 
cell brush border 
Basement membrane 
Basement membrane 
Extracellular 
matrix 
Extracellular 
matrix 
+++ +++ 
+++ +++ 
++ +++ 
+ +  
- -  
+++ + 
+ +  
+ +  
++++ ++++ 
++ + 
++ ++ ++ 
++ ++ ++ 
++ ++ ++ 
+ + +  
- ++ ++ 
++ ++ ++ 
- + ++ 
++ ++ - 
++++ ++++ ++++ 
+ ++ ND 
*Slides were observed and scored on a relative scale as - (negative) to ++++ 
(maximum staining; very dark positive for >90% of the cells); + indicates 
weaker staining for -2s-SO% of the cells; ++ indicates moderate staining for 
greater than 50-7S% of the cells. 
Samples from the RWV cultures were taken for scanning 
electron microscopy at the same times as those taken for 
immunocytochemistry. After removal from the reactor 
vessels, samples were washed once with CMF-PBS. The 
samples were suspended in a buffer containing 3% glutaral- 
dehyde and 2% paraformaldehyde in 0.1M cacodylate buffer 
at pH 7.4, then rinsed for 5 minutes with cacodylate buffer 
three times and postfixed with 1% osmium tetroxide 
(Electron Microscopy Sciences, Fort Washington, Pa.) in 
cacodylate buffer for 1 hour. Samples were then rinsed for 
5 minutes with distilled water three times and then treated 
for 10 minutes with Millipore (Millipore Corp., Bedford, 
Mass.) (0.24 filtered, saturated solution of thiocarbohy- 
drazide (Electron Microscopy Sciences), then washed for 5 
minutes with distilled water five times and fixed with 1% 
buffered osmium tetroxide for 10 minutes. This last step was 
necessary to prevent the microcarriers from collapsing. 
Samples were then rinsed with distilled water three times 
and dehydrated with increasing concentrations of EtOH 
followed by three changes in absolute methanol. After 
transfer to 1, 1, 1, 3, 3, 3-hexamethyldisilazane (HMDS) 
(Electron Microscopy Sciences) samples were allowed to 
soak for 10 minutes, drained, and air dried overnight. Dried 
samples were sprinkled with a thin layer of silver paint on 
a specimen stub, dried, coated by vacuum evaporation with 
platinum-palladium alloy, and then examined in the JEOL 
T330 Scanning electron microscope at an accelerating volt- 
age of 5 to 10 kV. 
Micrographs taken of 6- to 7-day cocultures showed 
partial coverage of the microcarriers by normal small intes- 
tine mesenchymal cells. Additionally, large developing 
masses of small intestine epithelium were evident, growing 
on the microcarrier beadpacks. Samples harvested at 
approximately 12 days of culture contained small microcar- 
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rier packs which were totally engulfed in proliferating small 
intestine epithelium. Micrographs of samples at 13 days 
displayed large tissue-like masses that were entirely covered 
with small intestine epithelium grown on a base layer of 
mesenchymal cells. Areas of organized columnar epithelium 
were prominent. As the cultures matured into mid- and 
late-stage cultures, extremely complex tissue-like masses 
comprised of mesenchymal and epithelial cells were seen 
from approximately 16 days of culture until termination at 
41 days. These tissues were assembled from smaller masses 
which were joined by cord-like structures of fibroblasts and 
covered by epithelial cells several layers deep. In addition, 
available microcarriers were drawn to the surface of these 
large masses which were approximately 0.3 to 0.5 cm in 
diameter. Finally, columnar epithelium was observed to be 
growing even in the recessed areas of the microcarrier bead 
packs. 
The artificially produced mammalian structural tissue was 
generated from normal mouse embryonic femurs. The fetal 
cells are a mixture of chondrocytes and stromal cells. The 
cells were placed in a standard media commonly designated 
as CMRL 1066 (Gibco Labs) containing 10% Fetal Bovine 
Serum. The cells were disassociated by standard enzymatic 
digestion. The single cells produced by enzymatic digestion 
were washed several times in PBS and transferred into a 
culture vessel with fluid culture media. The preferred culture 
vessel is described in U.S. Pat. No. 5,026,650 and referenced 
above. The vessel was steam sterilized by autoclaving at 
standard temperature and pressure prior to transfer of the 
cells. 
A preferred culture matrix of generally spherical micro- 
carrier Cytodex-3 beads were transferred into the culture 
vessel. The approximate total cell inoculum was 132,000, 
000 at a ratio of 30 cells per Cytodex-3 microcarrier bead. 
The bead concentration of the vessel was 10 mgiml (4000 
beadsimg). The culture media in the vessel was CMRL 1066 
with ascorbic acid 10 mgiml added. 
Microgravity conditions were simulated in culture vessel 
as described and referenced herein. The vessel provided the 
quiescent well-perfused environment for maintenance of 
cell surface receptors and undisturbed cell-to-cell 
co-location. Co-location is important for autocrine-paracrine 
factor formation and exchange between cellular types, and 
nurturing of differentiation with consequential matrix depo- 
sition. The cells were cultured for up to 65 days. The tissue 
masses grew to at least 0.4 cm in length after 1000 hours of 
culture. The development of normal cartilage tissue was 
evidenced by normal morphology of the chondrocyte and 
stromal cell formation and cartilagineous tissue substruc- 
tures. Also, tissue with calcification was produced. Also, 
proteoglycan deposition was identified. The normal pattern 
of Type I1 collagen deposition followed by down regulation 
of Type I1 collagen deposition and enhanced formation of 
Type IX and Type X collagen was observed. 
Photographs taken during the culture period of the struc- 
tural cells show the growth and normal development of the 
tissue. FIG. 6 is a micrograph taken at 500x magnification 
at 300 to 600 hours of culture of normal fetal mouse 
chondrocytes. The cells grew around the generally spherical 
microcarriers. FIG. 7 is a higher magnification showing 
preliminary calcification at the arrow 20. FIGS. 8 and 9 were 
taken after 900 to 1100 hours of culture with differentiated 
fibroblastic chondrocytes shown in FIG. 9 at 22. Also, 
stromal cells are show in FIG. 9 at 24. 
The artificially produced blood tissue can be made from 
human bone marrow samples or other sources of mamma- 
lian origin. Human bone marrow samples are obtained by 
standard clinical techniques under aseptic conditions. In 
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general, a bone marrow tool is used to puncture the bone and 
obtain a bone marrow sample that is fully inclusive of 
normal constituents. The normal constituents will include, 
but are not limited to: pleuripotential stem cells, fully 
maturated white blood cells and red blood cells, stromal 
components, and cells in intermediate stages of maturation. 
Laboratory animals such as mice can be used as a source 
of bone marrow for selected studies. After sacrificing mice, 
the femur and tibia are removed and placed in IxCalcium- 
and Magnesium-free PBS with 200 pgiml pen-strep. Muscle 
is removed and endcaps of the bones are cut. With a syringe 
and 26G needle, the bone is flushed with cold complete 
growth medium known to those skilled in the art such as 
CMRL 1066. Cells are then poured through collector screens 
to remove large pieces of tissue and suspended cells are 
placed in 50-cc sterile tubes on cold complete growth 
medium. Cells are washed and centrifuged three times to 
insure no contamination. Cells are not treated with any 
reagent to remove red blood cells. 
The preferred culture vessel is described in U.S. Pat. No. 
5,026,650 previously cited and incorporated by reference 
herein. A fluid culture media is introduced into the sterilized 
vessel. A preferred fluid culture media is a standard tissue 
culture media commonly designated as RPM1-1640 
(available from Gibco and other sources). 
The sterile bone marrow cells are then transferred to fluid 
culture medium and suspended. Suspended cells are 
transferred, at approximate densities of 1x106 cellsiml, to 
the culture vessel. Various cell matrices can be used. The 
collected bone marrow cells can be encased in stromal-like 
matrices. The matrices can be disc-shaped. Other matrices 
are generally known can be used including, but are not 
limited to, collagen matrices of Type I rat tail collagen or 
other biopolymeric matrices. The biopolybers used can be 
biodegradable such as suture materials. Cross-linked poly- 
mers such as collagen, fibronectin and mixtures thereof may 
be used. These matrices may have spherical diameters 
ranging from 1 millimeter to 10 millimeters and include the 
necessary cellular constituents to facilitate primary bone 
marrow culture. Cytodex-3 microcarriers can be introduced 
into the vessel at a density of 5 mgiml. Bone marrow cells 
contained in the matrix or supported in suspension are 
cultured at microgravity conditions and mass transfer as 
described herein and the incorporated references. 
Early in the initiation it is preferable that the cells are 
allowed to grow and metabolize without sampling interrup- 
tion. The first sampling may begin one to seven days after 
inoculation. Consequently, cellular aggregates are not dis- 
turbed and bone marrow growth factors are not diluted by 
media repletion. After the lag phase, media repletion is 
based upon requirements as previously described. Cellular 
phenotyping is carried out by flow cytometry and light 
microscopy. 
FIG. 10 is a schematic drawing of the bone marrow cell 
production. The disc-shaped culture matrices are shown at 
30,32 and 34. The bone marrow cells are shown as circular 
14 
figures at 36, 38 and 40. The arrows with the GF generally 
indicate the excretion of growth factors from the normal 
bone marrow cells that enhance tissue growth in the culture 
system. 
In the case of preparing bone marrow for recipients, 
volumes are expanded as cellular densities or metabolic 
requirements dictate. The limited parameters may depend 
upon the rotating vessel’s ability to suspend large 
aggregates, in which case if unable to suspend large 
10 aggregates, smaller aggregates would be distributed through 
several vessels. If the metabolic requirements were such that 
mass transfer of oxygen and removal of carbon dioxide were 
not sufficient to maintain cellular growth and expansion, 
then cells would be aliquoted into additional vessels. 
The examples included are not intended to limit the scope 
of the present invention. Normal mammalian cells have been 
cultured to produce aggregates of cells of three dimensional 
tissue masses. Other substitutions, modifications and varia- 
tions are apparent to those skilled in the art without depart- 
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What we claim is: 
1. Aculture medium for non-neoplastic mammalian organ 
(a) minimal essential medium-alpha (MEM-ALPHATM); 
(b) Leibovitz L-lSTM medium; 
(c) tri-sugar supplement; and 
(d) serum. 
2. The culture medium of claim 1 wherein the tri-sugar 
30 supplement is selected from mixtures of the group consisting 
of fructose, galactose, and glucose. 
3. The culture medium of claim 2 wherein said concen- 
tration of fructose ranges from about 65 mgiliter to about 
500 mdliter. 
4. The culture medium of claim 2 wherein said concen- 
tration of galactose ranges from about 125 mdliter to about 
900 mdliter. 
5 .  The culture medium of claim 2 wherein said concen- 
tration of glucose ranges from about 500 mgiliter to about 
6. The culture medium of claim 1 wherein the medium 
further comprises sodium bicarbonate (NaHCO,). 
7. The culture medium of claim 1 wherein the MEM- 
ALPHATM base medium and LEIBOVITZ L-lSTM medium 
4s are in a 4:6 ratio. 
8. The culture medium of claim 1 wherein said serum is 
selected from the group consisting of bovine serum and calf 
serum. 
9. The culture medium of claim 1 wherein said serum 
10. The culture medium claim 1 further comprising 
gentamycin, fungizone, NaHCO,, HEPES, folic acid, nico- 
tinic acid, bactopeptone, i-inositol, L-glutamine, and 
insulin-transferrin-sodium selenite solution. 
tissue culture comprising: 
2s 
3s 
40 4500 mgiliter. 
SO concentration ranges from about 3% to about 25%. 
5s 
* * * * *  
